×
About 27,564 results

ALLMedicine Atopic Dermatitis Center

Research & Reviews  12,089 results

The effectiveness of JAK inhibitors in treating atopic dermatitis: a systematic review ...
https://doi.org/10.1111/dth.13685
Dermatologic Therapy; Arora CJ, Khattak FA et. al.

May 27th, 2020 - Primary studies have presented conflicting results on the efficacy of Janus kinase (JAK) inhibitors in treating atopic dermatitis. Hence, it is important to determine the summary effect of JAK inhibitors in order to guide the clinical application ...

Outside-in hypothesis revisited: the role of microbial, epithelial and immune interacti...
https://doi.org/10.1016/j.anai.2020.05.016
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology; Sugita K, Soyka MB et. al.

May 26th, 2020 - Our understanding of the origin of allergic diseases has increased in recent years, highlighting the importance of microbial dysbiosis and epithelial barrier dysfunction in affected tissues. Exploring the microbial-epithelial-immune crosstalk unde...

Initial validation of the product of the signs global assessment and body surface area ...
https://doi.org/10.1016/j.jaad.2020.05.095
Journal of the American Academy of Dermatology; Topham C, Haynes D et. al.

May 26th, 2020 - Current valid instruments that measure the signs of AD in clinical trials may not be suitable for clinical practice due to their complexity. The product of a clinician-derived 5-point signs global assessment and body surface area (SGAxBSA) may rep...

Considerations for Safety in the Use of Systemic Medications for Psoriasis and Atopic D...
https://doi.org/10.1111/dth.13687
Dermatologic Therapy; Ricardo JW, Lipner SR

May 26th, 2020 - Coronavirus disease 2019 (COVID-19), is responsible for at least 2,546,527 cases and 175,812 deaths as of April 21, 2020. Psoriasis and atopic dermatitis are common, chronic, inflammatory skin conditions, with immune dysregulation as a shared mech...

A Phase IIb, Randomized Clinical Trial of Tapinarof Cream for the Treatment of Plaque P...
https://doi.org/10.1016/j.jaad.2020.04.181
Journal of the American Academy of Dermatology; Gold LS, Bhatia N et. al.

May 24th, 2020 - Tapinarof cream is a topical therapeutic aryl hydrocarbon receptor modulating agent (TAMA) under investigation for treatment of psoriasis and atopic dermatitis. In a phase IIb, double-blind, vehicle-controlled study, adults with plaque psoriasis w...

see more →

Guidelines  25 results

European task force on atopic dermatitis position paper: treatment of parental atopic d...
https://doi.org/10.1111/jdv.15709
Journal of the European Academy of Dermatology and Venereology : JEADV References; Vestergaard C, Wollenberg A et. al.

Jun 24th, 2019 - Atopic dermatitis (AD) is a common inflammatory skin disease that affects both children and adults, including a large number of adults of reproductive age. Several guidelines for the treatment of AD exist, yet specific recommendations for the trea...

Atopic dermatitis/Eczema | DermNet NZ
https://www.dermnetnz.org/topics/atopic-dermatitis/

Jun 24th, 2019 - Atopic dermatitis is a chronic, itchy skin condition that is very common in children but may occur at any age. It is also known as eczema and atopic eczema and was formerly known as Besnier prurigo. It is the most common form of dermatitis. Atopi...

Eczema - StatPearls
https://www.ncbi.nlm.nih.gov/books/NBK538209/
Nemeth,V.,et al

Jun 3rd, 2019 - Eczema, also known as atopic dermatitis, is the most common form of dermatitis. Genetic as well as environmental factors are thought to play a part in the pathogenesis. Eczema is most commonly seen in children but can be seen in adults. People ...

The Effects of Early Nutritional Interventions on the Development of Atopic Disease in Infants and Children: The Role of Maternal Dietary Restriction, Breastfeeding, Hydrolyzed Formulas, and Timing...
https://doi.org/10.1542/peds.2019-0281

Mar 17th, 2019 - This clinical report updates and replaces a 2008 clinical report from the American Academy of Pediatrics, which addressed the roles of maternal and early infant diet on the prevention of atopic disease, including atopic dermatitis, asthma, and foo...

Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) ...
https://doi.org/10.1111/jdv.14891
Journal of the European Academy of Dermatology and Venereology : JEADV; Wollenberg A, Barbarot S et. al.

Apr 20th, 2018 - This guideline was developed as a joint interdisciplinary European project, including physicians from all relevant disciplines as well as patients. It is a consensus-based guideline, taking available evidence from other guidelines, systematic revi...

see more →

Drugs  577 results see all →

Clinicaltrials.gov  13,301 results

The effectiveness of JAK inhibitors in treating atopic dermatitis: a systematic review ...
https://doi.org/10.1111/dth.13685
Dermatologic Therapy; Arora CJ, Khattak FA et. al.

May 27th, 2020 - Primary studies have presented conflicting results on the efficacy of Janus kinase (JAK) inhibitors in treating atopic dermatitis. Hence, it is important to determine the summary effect of JAK inhibitors in order to guide the clinical application ...

Outside-in hypothesis revisited: the role of microbial, epithelial and immune interacti...
https://doi.org/10.1016/j.anai.2020.05.016
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology; Sugita K, Soyka MB et. al.

May 26th, 2020 - Our understanding of the origin of allergic diseases has increased in recent years, highlighting the importance of microbial dysbiosis and epithelial barrier dysfunction in affected tissues. Exploring the microbial-epithelial-immune crosstalk unde...

Initial validation of the product of the signs global assessment and body surface area ...
https://doi.org/10.1016/j.jaad.2020.05.095
Journal of the American Academy of Dermatology; Topham C, Haynes D et. al.

May 26th, 2020 - Current valid instruments that measure the signs of AD in clinical trials may not be suitable for clinical practice due to their complexity. The product of a clinician-derived 5-point signs global assessment and body surface area (SGAxBSA) may rep...

Considerations for Safety in the Use of Systemic Medications for Psoriasis and Atopic D...
https://doi.org/10.1111/dth.13687
Dermatologic Therapy; Ricardo JW, Lipner SR

May 26th, 2020 - Coronavirus disease 2019 (COVID-19), is responsible for at least 2,546,527 cases and 175,812 deaths as of April 21, 2020. Psoriasis and atopic dermatitis are common, chronic, inflammatory skin conditions, with immune dysregulation as a shared mech...

FDA Approves New Biologic for Atopic Dermatitis in Children
https://www.medscape.com/viewarticle/931219

May 26th, 2020 - The Food and Drug Administration has approved dupilumab for children aged 6-11 years with moderate to severe atopic dermatitis, the manufacturers announced. The new indication is for children "whose disease is not adequately controlled with topica...

see more →

News  1,545 results

FDA Approves New Biologic for Atopic Dermatitis in Children
https://www.medscape.com/viewarticle/931219

May 26th, 2020 - The Food and Drug Administration has approved dupilumab for children aged 6-11 years with moderate to severe atopic dermatitis, the manufacturers announced. The new indication is for children "whose disease is not adequately controlled with topica...

Sanofi and Regeneron's Dupixent shows more encouraging results
https://www.reuters.com/article/us-sanofi-regeneron-dupixent/sanofi-and-regenerons-dupixent-shows-more-encouraging-results-idUSKBN21L0K6

Apr 3rd, 2020 - PARIS (Reuters) - Healthcare companies Sanofi and Regeneron announced on Friday more encouraging results for their Dupixent product used to treat severe atopic dermatitis, often commonly known as eczema. The companies said that Dupixent Phase 3 da...

Routinely screen for depression in atopic dermatitis
https://www.mdedge.com/pediatrics/article/220092/atopic-dermatitis/routinely-screen-depression-atopic-dermatitis?channel=53
Bruce Jancin

Apr 2nd, 2020 - Screening for depression in patients with atopic dermatitis is a vital task that’s woefully neglected – and dermatologists aren’t doing any better a job of it than primary care physicians, Jonathan I. Silverberg, MD, PhD, declared in a video prese.

New topicals coming for pediatric atopic dermatitis
https://www.mdedge.com/clinicianreviews/article/219636/atopic-dermatitis/new-topicals-coming-pediatric-atopic-dermatitis?channel=53
Bruce Jancin

Mar 26th, 2020 - LAHAINA, HAWAII – Novel topical medications are in the works that will address the longstanding unmet need for a Food and Drug Administration–approved noncorticosteroid topical for use in pediatric atopic dermatitis, Lawrence F. Eichenfield, MD, r.

Colloidal Oatmeal: Optimal Skin-Directed Care for Atopic Dermatitis
https://www.mdedge.com/pediatrics/article/219464/colloidal-oatmeal-optimal-skin-directed-care-atopic-dermatitis?channel=167

Mar 23rd, 2020 - Click to read. Atopic dermatitis (AD) is a chronic, relapsing inflammatory skin disease that affects approximately 10% of US children.

see more →

Patient Education  27 results see all →